Oncolytic immunotherapeutic virus in HCC: can it compete with molecular therapies?
J Hepatol
.
2013 Oct;59(4):882-4.
doi: 10.1016/j.jhep.2013.05.006.
Epub 2013 May 11.
Authors
Virginia Hernandez-Gea
1
,
Clara Alsinet
,
Josep M Llovet
Affiliation
1
HCC Translational Research Laboratory, Barcelona-Clínic Liver Cancer Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Universitat de Barcelona (UB), Barcelona, Catalonia, Spain.
PMID:
23673136
DOI:
10.1016/j.jhep.2013.05.006
No abstract available
Keywords:
Hepatocellular carcinoma; Immunotherapy; Oncolytic virus.
Publication types
Comment
MeSH terms
Carcinoma, Hepatocellular / therapy*
Female
Humans
Liver Neoplasms / therapy*
Male
Oncolytic Virotherapy*
Vaccinia virus / genetics*